miRNA-based signature for predicting epithelial ovarian cancer recurrence

被引:1
作者
De Cecco, Loris [1 ]
Bagnoli, Marina [2 ]
Canevari, Silvana [1 ]
Califano, Daniela [3 ]
Perrone, Francesco [4 ]
Pignata, Sandro [5 ]
Mezzanzanica, Delia [2 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Funct Genom, Dept Expt Oncol & Mol Med, Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Mol Therapies Unit, Dept Expt Oncol & Mol Med, Via Amadeo 42, I-20133 Milan, Italy
[3] Fdn G Pascale, IRCCS, Ist Nazl Studio & Cura Tumori, Funct Genom Unit, Naples, Italy
[4] Fdn G Pascale, IRCCS, Ist Nazl Studio & Cura Tumori, Clin Trials Unit, Naples, Italy
[5] Fdn G Pascale, IRCCS, Ist Nazl Studio & Cura Tumori, Dept Urogynaecol Oncol, Naples, Italy
关键词
EARLY RELAPSE; PROGRESSION; PROGNOSIS;
D O I
10.21037/tcr.2017.02.44
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S232 / S234
页数:3
相关论文
共 10 条
[1]   Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study [J].
Bagnoli, Marina ;
Canevari, Silvana ;
Califano, Daniela ;
Losito, Simona ;
Di Maio, Massimo ;
Raspagliesi, Francesco ;
Carcangiu, Maria Luisa ;
Toffoli, Giuseppe ;
Cecchin, Erika ;
Sorio, Roberto ;
Canzonieri, Vincenzo ;
Russo, Daniela ;
Scognamiglio, Giosue ;
Chiappetta, Gennaro ;
Baldassarre, Gustavo ;
Lorusso, Domenica ;
Scambia, Giovanni ;
Zannoni, Gian Franco ;
Savarese, Antonella ;
Carosi, Mariantonia ;
Scollo, Paolo ;
Breda, Enrico ;
Murgia, Viviana ;
Perrone, Francesco ;
Pignata, Sandro ;
De Cecco, Loris ;
Mezzanzanica, Delia .
LANCET ONCOLOGY, 2016, 17 (08) :1137-1146
[2]   Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients [J].
Bagnoli, Marina ;
De Cecco, Loris ;
Granata, Anna ;
Nicoletti, Roberta ;
Marchesi, Edoardo ;
Alberti, Paola ;
Valeri, Barbara ;
Libra, Massimo ;
Barbareschi, Mattia ;
Raspagliesi, Francesco ;
Mezzanzanica, Delia ;
Canevari, Silvana .
ONCOTARGET, 2011, 2 (12) :1265-1278
[3]   A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment [J].
Calura, E. ;
Paracchini, L. ;
Fruscio, R. ;
DiFeo, A. ;
Ravaggi, A. ;
Peronne, J. ;
Martini, P. ;
Sales, G. ;
Beltrame, L. ;
Bignotti, E. ;
Tognon, G. ;
Milani, R. ;
Clivio, L. ;
Dell'Anna, T. ;
Cattoretti, G. ;
Katsaros, D. ;
Sartori, E. ;
Mangioni, C. ;
Ardighieri, L. ;
D'Incalci, M. ;
Marchini, S. ;
Romualdi, C. .
ANNALS OF ONCOLOGY, 2016, 27 (08) :1511-1519
[4]   miRNA based signature for predicting epithelial ovarian cancer relapse-progression: a step forward to prime time clinical adoption? [J].
Ceppi, Lorenzo ;
Marchini, Sergio ;
Fruscio, Robert .
TRANSLATIONAL CANCER RESEARCH, 2016, 5 :S664-S667
[5]   Commentary on microRNA Fingerprint in Human Epithelial Ovarian Cancer [J].
Iorio, Marilena V. ;
Croce, Carlo M. .
CANCER RESEARCH, 2016, 76 (21) :6143-6145
[6]   Ovarian cancer [J].
Jayson, Gordon C. ;
Kohn, Elise C. ;
Kitchener, Henry C. ;
Ledermann, Jonathan A. .
LANCET, 2014, 384 (9951) :1376-1388
[7]   Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers [J].
Liu, Guoyan ;
Yang, Da ;
Rupaimoole, Rajesha ;
Pecot, Chad V. ;
Sun, Yan ;
Mangala, Lingegowda S. ;
Li, Xia ;
Ji, Ping ;
Cogdell, David ;
Hu, Limei ;
Wang, Yingmei ;
Rodriguez-Aguayo, Cristian ;
Lopez-Berestein, Gabriel ;
Shmulevich, Ilya ;
De Cecco, Loris ;
Chen, Kexin ;
Mezzanzanica, Delia ;
Xue, Fengxia ;
Sood, Anil K. ;
Zhang, Wei .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07)
[8]   Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections [J].
Marchini, Sergio ;
Cavalieri, Duccio ;
Fruscio, Robert ;
Calura, Enrica ;
Garavaglia, Daniela ;
Nerini, Ilaria Fuso ;
Mangioni, Costantino ;
Cattoretti, Giorgio ;
Clivio, Luca ;
Beltrame, Luca ;
Katsaros, Dionyssios ;
Scarampi, Luca ;
Menato, Guido ;
Perego, Patrizia ;
Chiorino, Giovanna ;
Buda, Alessandro ;
Romualdi, Chiara ;
D'Incalci, Maurizio .
LANCET ONCOLOGY, 2011, 12 (03) :273-285
[9]   MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer [J].
Sun, Yan ;
Hu, Limei ;
Zheng, Hong ;
Bagnoli, Marina ;
Guo, Yuhong ;
Rupaimoole, Rajesha ;
Rodriguez-Aguayo, Cristian ;
Lopez-Berestein, Gabriel ;
Ji, Ping ;
Chen, Kexin ;
Sood, Anil K. ;
Mezzanzanica, Delia ;
Liu, Jinsong ;
Sun, Baocun ;
Zhang, Wei .
JOURNAL OF PATHOLOGY, 2015, 235 (01) :25-36
[10]   On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles [J].
Wan, Ying-Wooi ;
Mach, Claire M. ;
Allen, Genevera I. ;
Anderson, Matthew L. ;
Liu, Zhandong .
PLOS ONE, 2014, 9 (01)